Streetbeat News

Products Services

GRMN

Garmin (NYSE:GRMN) has secured a 5-year exclusive deal as the sole electronics and audio supplier for Independent Boat Builders, Inc. (IBBI), starting from model year 2025 through 2029. This agreement strengthens Garmin's long-standing relationship with IBBI, which builds over 25% of all boats sold in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:07 am

GILT

Gilat Satellite Networks' US-based subsidiary, DataPath, has received over $9 million in orders to support the US Department of Defense and other global agencies in field service and technology service programs.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:07 am

BITB

FBTC

Bitcoin spot ETFs have seen significant net inflows, with Fidelity ETF (FBTC) and Bitwise ETF (BITB) attracting substantial investments. The US SEC has received an application for the Hashdex Nasdaq Crypto Index US ETF, which will hold both Bitcoin and Ethereum. This development could further boost inflows into these cryptocurrencies.

Portfolio Pulse from Murtuza Merchant

July 02, 2024 | 11:07 am

PBA

Pembina Pipeline Corporation (NYSE: PBA) and KKR have partnered to acquire a 50% stake in Whitecap's Kaybob Gas Complex for $420 million. The transaction includes long-term take-or-pay agreements and future infrastructure development support for Whitecap's Lator growth area.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:05 am

ARDX

Ardelyx has decided not to apply for the inclusion of its drug Xphozah (Tenapanor) in the CMS End-Stage Renal Disease Prospective Payment System due to concerns that the policy would restrict patient access and interfere with healthcare decision-making.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:04 am

ANIP

ANI Pharmaceuticals has received FDA approval and launched its Naproxen Delayed-Release Tablets, USP.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:03 am

LASE

Laser Photonics has announced its expansion to a new, larger facility in Florida. This move is expected to enhance their production capabilities and support future growth.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:02 am

RNAC

Cartesian Therapeutics has dosed the first patient in its Phase 2 open-label clinical trial evaluating Descartes-08 for the treatment of Systematic Lupus Erythematosus.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 10:34 am

RNAC

Cartesian Therapeutics announced positive topline results from its Phase 2B trial of Descartes-08 in patients with generalized myasthenia gravis. The trial met its primary endpoint with statistical significance, showing a 71% improvement in MGC score at Month 3 for treated patients compared to 25% for placebo. The company plans to hold an End-of-Phase 2 meeting with the FDA by year-end.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 10:32 am

BA

EADSY

Cebu Pacific Air has chosen Airbus over Boeing for a record $24 billion deal to purchase 152 single-aisle jets. This decision comes as Boeing faces safety and regulatory challenges, while Airbus strengthens its market position.

Portfolio Pulse from Benzinga Neuro

July 02, 2024 | 10:29 am